Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Daniele Di Giulio Cesare"'
Autor:
Cristina Scavone, Antonietta Anatriello, Isabella Baccari, Andrea Cantone, Daniele Di Giulio Cesare, Francesca Futura Bernardi, Ornella Moreggia, Valerio Liguori, Vincenzo Andreone, Giorgia Teresa Maniscalco, Annalisa Capuano
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionIn 2021 ofatumumab, a recombinant human anti-CD20 monoclonal antibody (mAb) already authorized for the treatment of chronic lymphocytic leukemia, received the marketing approval for the treatment of relapsing forms of multiple sclerosis (
Externí odkaz:
https://doaj.org/article/6e8f6ecdf90846e894bfbccc0a7fd25e
Autor:
Cristina Scavone, Valerio Liguori, Olusola Jephthah Adungba, Daniele Di Giulio Cesare, Maria Giuseppa Sullo, Vincenzo Andreone, Liberata Sportiello, Giorgia Teresa Maniscalco, Annalisa Capuano
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionDisease modifying therapies (DMTs) used to treat multiple sclerosis (MS) can be associated to the occurrence of hematological disorders. This systematic review aims to provide an overview of these events occurring in real-life conditions,
Externí odkaz:
https://doaj.org/article/5cfd44f48fa14327922106981292d413
Autor:
Antonio Ziello, Cristina Scavone, Maria Elena Di Battista, Simona Salvatore, Daniele Di Giulio Cesare, Ornella Moreggia, Lia Allegorico, Anna Sagnelli, Stefano Barbato, Valentino Manzo, Annalisa Capuano, Giorgia Teresa Maniscalco
Publikováno v:
Brain Sciences, Vol 11, Iss 7, p 890 (2021)
Background. The so-called “vaccine hesitancy” still represents a common phenomenon that undermines the effectiveness of vaccination campaigns. In 2020, the Italian Medicines Agency recommended to bring forward the flu vaccination campaign, whose
Externí odkaz:
https://doaj.org/article/685935fc0de3409b8afcf39f86225e9c
Autor:
Capuano, Giorgia Teresa Maniscalco, Daniele Di Giulio Cesare, Valerio Liguori, Valentino Manzo, Elio Prestipino, Simona Salvatore, Maria Elena Di Battista, Ornella Moreggia, Antonio Rosario Ziello, Vincenzo Andreone, Cristina Scavone, Annalisa
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4236
Since the beginning of the mass immunization of patients with multiple sclerosis (MS), many data on the efficacy and safety of COVID-19 vaccines have been produced. Considering that MS is an autoimmune disease and that some disease-modifying therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::51aa9852c9f8b601dcfad0f0a8060068
Autor:
Giorgia Teresa, Maniscalco, Cristina, Scavone, Ornella, Moreggia, Daniele, Di Giulio Cesare, Maria Luisa, Aiezza, Gaspare, Guglielmi, Giuseppe, Longo, Massimo, Maiolo, Eliana, Raiola, Giuseppe, Russo, Annalisa, Capuano
Publikováno v:
Expert Opinion on Drug Safety. 21:979-984
In 2020, the Italian Medicines Agency recommended to bring forward the flu vaccination campaign, whose importance was also emphasized for patients with Multiple Sclerosis (MS). We aimed to assess the safety profile of flu vaccines in terms of occurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d67abe8e0b34d0b39d5418977129d62
https://doi.org/10.1080/14740338.2022.2044787
https://doi.org/10.1080/14740338.2022.2044787
Autor:
Giorgia Teresa Maniscalco, Anne Lise Ferrara, Antonietta Liotti, Valentino Manzo, Maria Elena Di Battista, Simona Salvatore, Daniela Graziano, Assunta Viola, Gerardino Amato, Ornella Moreggia, Daniele Di Giulio Cesare, Gennaro Alfieri, Walter Di Iorio, Gennaro Della Rocca, Vincenzo Andreone, Veronica De Rosa
Publikováno v:
Multiple sclerosis and related disorders. 62
The persistence of the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 pandemic, partly due to the appearance of highly infectious variants, has made booster vaccinations necessary for vulnerable groups. Here, we present data regarding the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7791a27ee1179e39026b860e02eeea
https://pubmed.ncbi.nlm.nih.gov/35462168
https://pubmed.ncbi.nlm.nih.gov/35462168
Autor:
Giorgia Teresa Maniscalco, Antonietta Liotti, Anne Lise Ferrara, Elio Prestipino, Simona Salvatore, Maria Elena Di Battista, Ornella Moreggia, Daniele Di Giulio Cesare, Roberta Vastano, Martina Belardo, Massimo Napolitano, Angelo Ranieri, Katia Longo, Vincenzo Andreone, Veronica De Rosa
Publikováno v:
Multiple Sclerosis and Related Disorders. 68:104371
It remains unclear how vaccine doses and combinations of vaccination and infection affect the magnitude and quality of immune responses, particularly against novel SARS-CoV-2 variants in subjects with immune-related disorders, such as people with mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53300bd9f0060206ac88cc2f28d9ccd5
https://doi.org/10.1016/j.msard.2022.104371
https://doi.org/10.1016/j.msard.2022.104371
Autor:
Giorgia Teresa Maniscalco, Valentino Manzo, Anne Lise Ferrara, Alessandro Perrella, Mariaelena Di Battista, Simona Salvatore, Daniela Graziano, Assunta Viola, Gerardino Amato, Ornella Moreggia, Daniele Di Giulio Cesare, Stefano Barbato, Giovanna Servillo, Katia Longo, Mario Di Giovanni, Barbara Scarpati, Simona Maria Muggianu, Giuseppe Longo, Giuseppe Russo, Vincenzo Andreone, Veronica De Rosa
Publikováno v:
Multiple Sclerosis and Related Disorders
Background Several concerns exist on the immunogenicity of SARS-CoV-2 vaccines in multiple sclerosis (MS) subjects due to their immunomodulating disease modifying therapies (DMTs). Here we report a comparison of the humoral response to BNT162b2-mRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c82fbe1518caaaae464c3b2408be6e21
https://pubmed.ncbi.nlm.nih.gov/34929455
https://pubmed.ncbi.nlm.nih.gov/34929455
Autor:
Giorgia Teresa Maniscalco, Cristina Scavone, Annamaria Mascolo, Valentino Manzo, Elio Prestipino, Gaspare Guglielmi, Maria Luisa Aiezza, Santolo Cozzolino, Adele Bracco, Ornella Moreggia, Daniele Di Giulio Cesare, Antonio Rosario Ziello, Angela Falco, Marida Massa, Massimo Majolo, Eliana Raiola, Roberto Soprano, Giuseppe Russo, Giuseppe Longo, Vincenzo Andreone, Annalisa Capuano
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 22; Pages: 6855
In the current COVID-19 pandemic, patients diagnosed with multiple sclerosis (MS) are considered to be one of the highest priority categories, being recognized as extremely vulnerable people. For this reason, mRNA-based COVID-19 vaccines are strongly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd69b0c893ab2d450aff7644638d176a
https://doi.org/10.3390/jcm11226855
https://doi.org/10.3390/jcm11226855
Autor:
Stefano Barbato, Maria Elena Di Battista, Giorgia Teresa Maniscalco, Ornella Moreggia, Antonio Rosario Ziello, Simona Salvatore, Lia Allegorico, Anna Sagnelli, Valentino Manzo, Annalisa Capuano, Daniele Di Giulio Cesare, Cristina Scavone
Publikováno v:
Brain Sciences
Volume 11
Issue 7
Brain Sciences, Vol 11, Iss 890, p 890 (2021)
Volume 11
Issue 7
Brain Sciences, Vol 11, Iss 890, p 890 (2021)
Background. The so-called “vaccine hesitancy” still represents a common phenomenon that undermines the effectiveness of vaccination campaigns. In 2020, the Italian Medicines Agency recommended to bring forward the flu vaccination campaign, whose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7dfcae4d1a624afc7923bca8503feec
https://pubmed.ncbi.nlm.nih.gov/34356125
https://pubmed.ncbi.nlm.nih.gov/34356125